IHMT-MST1-39

N/A

Report date: 2023/04/11 17:34:47
NME

Base Information

Drug NameIHMT-MST1-39
Drug Alias NameIHMT-MST1-39
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMacrophage-stimulating protein receptor inhibitorsAMP-activated protein kinases activators
TargetsMacrophage-stimulating protein receptorAMP-activated protein kinases
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHefei Academy Of Physical Sciences, Chinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesHefei Academy Of Physical Sciences, Chinese Academy Of Sciences
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A